BBB

BANGKOK GENOMICS INNOVATION PUBLIC

No trades
See on Supercharts

BKGI fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Bangkok Genomics Innovation PCL engages in the provision of screening services for fetal chromosomal abnormalities. It offers screening for genetic abnormalities, analysis infectious disease group, cancer related screening, genetic code analysis with whole exome sequencing, individual genetic testing, newborn screening, basic health check-up, providing technology services and other medical products. The company was founded in 2017 and is headquartered in Bangkok, Thailand.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

BKGI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company